CORAL LABORATORIES
|
The Current P/E Ratio of CORAL LABORATORIES is 8.71.
Share Price | ₹655.8 | May 07,2025 |
Market Cap | ₹236.1 Cr | |
Earnings-TTM | ₹27.1 Cr | TTM-Standalone Results |
Price/Earnings | 8.71x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of CORAL LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹236.1 Cr] as on May 07,2025
(/) Earnings [ ₹27.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 8.71x ]
Thus, for CORAL LABORATORIES , the investors are currently willing to pay 8.71 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of CORAL LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of CORAL LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of CORAL LABORATORIES
PE Ratio Performance Analysis for CORAL LABORATORIES
- CORAL LABORATORIES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 8.91x.
- CORAL LABORATORIES 's operated at median p/e ratio of 8.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, CORAL LABORATORIES 's p/e ratio peaked in Mar2023 at 12.69x.
- CORAL LABORATORIES 's p/e ratio hit its five-year low in Mar2020 of 4.91x.
How does CORAL LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
CORAL LABORATORIES | 27.12 | 8.71 | 236.1 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 37.21 | 427,406.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 78.91 | 163,113.0 |
CIPLA LTD | 5,000.43 | 24.37 | 121,869.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 59.80 | 111,345.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 17.83 | 96,801.0 |
MANKIND PHARMA LTD | 2,050.73 | 48.89 | 100,259.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.43 | 89,232.8 |
LUPIN LTD | 2,892.10 | 32.70 | 94,563.0 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.86 | 69,524.9 |
ABBOTT INDIA LTD | 1,334.46 | 48.18 | 64,299.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs CORAL LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 8.71x |
Max industry PE | 78.91x |
Median industry PE | 32.70x |
Average industry PE | 35.99x |
You may also like the below Video Courses